COVID-19 Funding Opportunities
The Coronavirus Aid, Relief, and Economic Security (CARES) Act provides federal agencies with additional funds to support research on COVID-19 prevention, preparation and response. The Office of Research Development has compiled a list of funding opportunities currently available. Some may require multidisciplinary teams so consider collaborators and look for opportunities beyond the agencies you typically apply to for funding. Solicitations are organized by agency and in order of release, most recent first. Some opportunities will require quick turnaround times; deadlines are noted below. Check back with this page as new opportunities will be posted regularly.
NOTE: Most COVID-related research requires consideration of the Institutional Biosafety Committee. For more information, please contact Hope Smith-Sielicki with the Office of Research Compliance at smith@clemson.edu.
What to expect from the CARES Act:
- $75M in funding for the National Science Foundation (NSF) for RAPID grant awards
- $945M provided to the National Institutes of Health (NIH) for COVID-19 research
- $99M granted to the Department of Energy’s Office of Science to support the national laboratory system’s work on COVID-19
- $60M authorized to National Institute of Standards and Technology (NIST) with $50M for the Hollings Manufacturing Extension Partnership to support manufacturing research and $10M for Manufacturing USA to spend on pharmaceutical and biotech research
NSF Announcements
- NSF 20-065: Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 - March 25, 2020
- NSF 20-055: Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) - March 5, 2020
- NSF 20-052: Dear Colleague Letter on the Coronavirus Disease 2019 - March 4, 2020
NIH Announcements
The National Institutes of Health (NIH) is inviting proposals for administrative supplements and revision supplements from current grantees in support of urgent COVID-19 research projects. Through Notices of Special Interest (NOSI), individual Institutes are interested in proposals that address specific topics of interest to that Institute. The work proposed must be related to the original scope of work.
Investigators planning to submit an application in response to NOSIs are strongly encouraged to contact the relevant program officer listed on each solicitation to discuss the proposed project in the context of the parent award.
- NOT-MD-20-025: Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities - August 13, 2020; Expiration Date: May 8, 2023
- RFA-OD-20-023: Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) - August 6, 2020; Application Due Date: September 30, 2020
- RFA-OD-20-19: Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) - August 6, 2020; Application Due Date: September 30, 2020
- RFA-OD-20-16: Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) - August 6, 2020; Application Due Date: September 30, 2020
- RFA-TR-20-003: Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) - August 5, 2020; Applications accepted on rolling basis until January 24, 2021
- PAR-20-256: Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) - July 13, 2020; Deadline: Applications accepted on a rolling basis, beginning July 13, 2020
- RFA-DK-20-021: Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) - July 10, 2020; Application Due Date: December 16, 2020
- PAR-20-243: Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) - June 26, 2020; Deadlines: December 2, 2020; March 2, 2021
- PAR-20-234: NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) - June 15, 2020; Deadlines: October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2020; February 1, 2021
- NOT-TR-20-029:Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need - June 15, 2020; Expiration Date: November 11, 2020
- NOT-DC-20-008: Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders - June 4, 2020; Expiration Date: September 8, 2022
- NOT-MH-20-061: Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency caused by Coronavirus Disease 2019 (COVID-19) - June 4, 2020
- NOT-MD-20-023: Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) - June 3, 2020; First Estimated Application Due Date: July 22, 2020
- NOT-OD-20-107: Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) – related Research - May 27, 2020; First Available Due Date: June 22, 2020
- NIH POCTRN RADx: Fast-Track Program for COVID-19 Test Development and Distribution - Applications accepted on a rolling basis
- PAR-20-177: Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) - April 30, 2020; Expiration Date: April 30, 2021
- PAR-20-178: Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) - April 30, 2020; Expiration Date: April 30, 2021
- NOT-CA-20-054: Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis - April 28, 2020
- NOT-NS-051: Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System - April 30, 2020; Expiration Date: April 15, 2021
- NOT-TR-20-028: Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs - April 23, 2020; Expiration Date: November 11, 2020
- NOT-AA-20-011: Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) With the Mission of NIAAA - April 16, 2020; Expiration Date: April 16, 2021
- NOT-OD-20-097: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences - April 13, 2020; Expiration Date: April 1, 2021
- NOT-ES-20-020: Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) - April 10, 2020; Expiration Date: May 4, 2021
- NOT-EB-20-008: Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) - April 10, 2020;Expiration Date: November 10, 2020
- NOT-EB-20-007: Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) - April 10, 2020; Expiration Date: March 31, 2021
- NOT-EB-20-006: Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) - April 10, 2020;Expiration Date: March 31, 2021
- NOT-AT-20-011: Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) - April 10, 2020; Expiration Date: October 6, 2020
- NOT-ES-20-015: Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) - April 9, 2020; Expiration Date: May 4, 2021
- NOT-MD-20-019: Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities - April 9, 2020; Expiration Date: May 1, 2021
- NOT-TR-20-017: Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus - April 9, 2020; Expiration Date: January 26, 2022
- NOT-MH-20-047: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus - April 9, 2020; Expiration Date: April 16, 2021
- NOT-TR-20-016: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus - April 9, 2020; Expiration Date: January 26, 2022
- NOT-AG-20-022: Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) - April 2, 2020; Expiration Date: May 1, 2021
- NOT-TR-20-012: Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) - March 27, 2020; Expiration Date: October 17, 2020
- NOT-HS-20-008: Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Profession Responsiveness to COVID-19 - March 26, 2020
- NOT-GM-20-025: Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 - March 25, 2020; Expiration Date: February 6, 2021
- NOT-TR-20-011: Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need - March 24, 2020; Expiration Date: July 10, 2021
- NOT-DA-20-047: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus - March 19, 2020; Expiration Date: March 31, 2021
- NOT-HL-20-757: Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) - March 17, 2020; Expiration Date: October 6, 2020
Department of Energy (DOE) Announcements
- COVID-19 High Performance Computing Consortium - Applications accepted at any time
- Invitation for COVID-19 Scientific Questions - March 12, 2020
Department of Commerce
- PWEAA2020: FY 2020 EDA Public Works and Economic Adjustment Assistance Programs including CARES Act Funding - May 7, 2020; Applications accepted at any time
NASA Announcements
- RRNES20ZDA001N-RRNES: Rapid Response and Novel Research in Earth Sciences - February 14, 2020; Deadline: March 29, 2021
National Endowment for the Humanities (NEH) Announcement
Department of Health and Human Services Announcements
- BAA-18-100-SOL-00003: Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) - March 4, 2020; Deadline: October 31, 2020
- BAA-20-100-SOL-00002: BARDA's Division of Research Innovation & Ventures (DRIVe) Easy Broad Agency Announcement - February 3, 2020; Deadline: February 3, 2023
Other Announcements
- Ferring Pharmaceuticals: FERRING COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health - Deadline: October 31, 2020
- North Carolina Biotechnology Center: Flash Grants - Cycle 2 Deadline: November 11, 2020; Cycle 3 Deadline: March 10, 2021
- 23andMe: Research Innovation Collaborations Program for COVID-19 - Rolling Deadline
- Cisco: Science, Technology and Society Impact Grants - Rolling Deadline
- Harold and Leila Y. Mathers Charitable Foundation
- The Global Fund, COVID-19 Funding - 14 April 2020
- Fast Grants, Fast Funding for COVID-19 Science - Open call
- Oak Ridge National Laboratory (ORNL): Rapid Access Proposal for COVID-19 Research
- Mozilla, COVID-19 Solutions Fund
- Russell Sage Foundation: Research Grant with Special Emphasis on the Impacts of COVID-19
- AWS Diagnostic Development Initiative (DDI)